Skip to main content
. 2023 Apr 16;12(11):12325–12335. doi: 10.1002/cam4.5931

FIGURE 1.

FIGURE 1

Profiles associated with possible conversion therapy in patients with HCC treated with Atez/Bev. Eligibility for conversion therapy. The pie graphs indicate the percentage of possible conversion therapy (white)/impossible conversion therapy (black) in each group. HCC, hepatocellular carcinoma.